Compounding, Drug Development and Generic Medicine

Small molecule API market to value $284.7 billion by 2032

European Pharmaceutical Review

JULY 25, 2023

A compound annual growth rate (CAGR) growth of 5.9 The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. This is a rise from $162.8 billion in 2022.

Compounding

Compounding Generic Medicine Drug Development Diabetes

Drug Repurposing: Unlocking access to rare solutions

Express Pharma

NOVEMBER 1, 2024

In the marathon of drug development, where billions of dollars and over a decade of research are the norm, drug repurposing is quietly reshaping the landscape. Evolving regulatory frameworks: One of the biggest hurdles is navigating the complex regulatory landscape that governs clinical drug development.

Drug Development

Drug Development Compounding Generic Medicine Vaccines

Pharmacist Digest

Small molecule API market to value $284.7 billion by 2032

Drug Repurposing: Unlocking access to rare solutions

Webinars

Stay Connected